These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 31924505)

  • 1. The phenotypic spectrum of SCN2A-related epilepsy.
    Reynolds C; King MD; Gorman KM
    Eur J Paediatr Neurol; 2020 Jan; 24():117-122. PubMed ID: 31924505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are SCN2A-related BFNISs also responsible for seizures in adulthood? A case report opens new scenarios.
    Brunetti S; Muda A; Conti C; Gazzina S; Accorsi P; Giordano L
    Am J Med Genet A; 2024 Nov; 194(11):e63813. PubMed ID: 38975734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic spectrum and genetics of SCN2A-related disorders, treatment options, and outcomes in epilepsy and beyond.
    Wolff M; Brunklaus A; Zuberi SM
    Epilepsia; 2019 Dec; 60 Suppl 3():S59-S67. PubMed ID: 31904126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders.
    Wolff M; Johannesen KM; Hedrich UBS; Masnada S; Rubboli G; Gardella E; Lesca G; Ville D; Milh M; Villard L; Afenjar A; Chantot-Bastaraud S; Mignot C; Lardennois C; Nava C; Schwarz N; Gérard M; Perrin L; Doummar D; Auvin S; Miranda MJ; Hempel M; Brilstra E; Knoers N; Verbeek N; van Kempen M; Braun KP; Mancini G; Biskup S; Hörtnagel K; Döcker M; Bast T; Loddenkemper T; Wong-Kisiel L; Baumeister FM; Fazeli W; Striano P; Dilena R; Fontana E; Zara F; Kurlemann G; Klepper J; Thoene JG; Arndt DH; Deconinck N; Schmitt-Mechelke T; Maier O; Muhle H; Wical B; Finetti C; Brückner R; Pietz J; Golla G; Jillella D; Linnet KM; Charles P; Moog U; Õiglane-Shlik E; Mantovani JF; Park K; Deprez M; Lederer D; Mary S; Scalais E; Selim L; Van Coster R; Lagae L; Nikanorova M; Hjalgrim H; Korenke GC; Trivisano M; Specchio N; Ceulemans B; Dorn T; Helbig KL; Hardies K; Stamberger H; de Jonghe P; Weckhuysen S; Lemke JR; Krägeloh-Mann I; Helbig I; Kluger G; Lerche H; Møller RS
    Brain; 2017 May; 140(5):1316-1336. PubMed ID: 28379373
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Yang XR; Ginjupalli VKM; Theriault O; Poulin H; Appendino JP; Au PYB; Chahine M
    J Neurophysiol; 2022 May; 127(5):1388-1397. PubMed ID: 35417276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infantile epileptic encephalopathy, transient choreoathetotic movements, and hypersomnia due to a De Novo missense mutation in the SCN2A gene.
    Hackenberg A; Baumer A; Sticht H; Schmitt B; Kroell-Seger J; Wille D; Joset P; Papuc S; Rauch A; Plecko B
    Neuropediatrics; 2014 Aug; 45(4):261-4. PubMed ID: 24710820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanded clinical phenotype spectrum correlates with variant function in SCN2A-related disorders.
    Berg AT; Thompson CH; Myers LS; Anderson E; Evans L; Kaiser AJE; Paltell K; Nili AN; DeKeyser JL; Abramova TV; Nesbitt G; Egan SM; Vanoye CG; George AL
    Brain; 2024 Aug; 147(8):2761-2774. PubMed ID: 38651838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and genetic spectrum of SCN2A-associated episodic ataxia.
    Schwarz N; Bast T; Gaily E; Golla G; Gorman KM; Griffiths LR; Hahn A; Hukin J; King M; Korff C; Miranda MJ; Møller RS; Neubauer B; Smith RA; Smol T; Striano P; Stroud B; Vaccarezza M; Kluger G; Lerche H; Fazeli W
    Eur J Paediatr Neurol; 2019 May; 23(3):438-447. PubMed ID: 30928199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further corroboration of distinct functional features in SCN2A variants causing intellectual disability or epileptic phenotypes.
    Begemann A; Acuña MA; Zweier M; Vincent M; Steindl K; Bachmann-Gagescu R; Hackenberg A; Abela L; Plecko B; Kroell-Seger J; Baumer A; Yamakawa K; Inoue Y; Asadollahi R; Sticht H; Zeilhofer HU; Rauch A
    Mol Med; 2019 Feb; 25(1):6. PubMed ID: 30813884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic action potential clamp predicts functional separation in mild familial and severe de novo forms of
    Berecki G; Howell KB; Deerasooriya YH; Cilio MR; Oliva MK; Kaplan D; Scheffer IE; Berkovic SF; Petrou S
    Proc Natl Acad Sci U S A; 2018 Jun; 115(24):E5516-E5525. PubMed ID: 29844171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the sodium channel gene SCN2A cause neonatal epilepsy with late-onset episodic ataxia.
    Schwarz N; Hahn A; Bast T; Müller S; Löffler H; Maljevic S; Gaily E; Prehl I; Biskup S; Joensuu T; Lehesjoki AE; Neubauer BA; Lerche H; Hedrich UBS
    J Neurol; 2016 Feb; 263(2):334-343. PubMed ID: 26645390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketogenic diet as a successful early treatment modality for SCN2A mutation.
    Turkdogan D; Thomas G; Demirel B
    Brain Dev; 2019 Apr; 41(4):389-391. PubMed ID: 30415926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of SCN2A-related disorder in the regional epilepsy centre of brescia between 2002 and 2021.
    Filippi C; Milito G; Accorsi P; Muda A; Fazzi EM; Martelli P; Riva A; Giordano L
    Clin Neurol Neurosurg; 2023 Nov; 234():107983. PubMed ID: 37776663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phenotype study of SCN2A gene related epilepsy].
    Zeng Q; Zhang YH; Yang XL; Zhang J; Liu AJ; Liu XY; Jiang YW; Wu XR
    Zhonghua Er Ke Za Zhi; 2018 Jul; 56(7):518-523. PubMed ID: 29996185
    [No Abstract]   [Full Text] [Related]  

  • 15. SCN2A channelopathies: Mechanisms and models.
    Hedrich UBS; Lauxmann S; Lerche H
    Epilepsia; 2019 Dec; 60 Suppl 3():S68-S76. PubMed ID: 31904120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological concepts in human sodium channel epilepsies and their relevance in clinical practice.
    Brunklaus A; Du J; Steckler F; Ghanty II; Johannesen KM; Fenger CD; Schorge S; Baez-Nieto D; Wang HR; Allen A; Pan JQ; Lerche H; Heyne H; Symonds JD; Zuberi SM; Sanders S; Sheidley BR; Craiu D; Olson HE; Weckhuysen S; DeJonge P; Helbig I; Van Esch H; Busa T; Milh M; Isidor B; Depienne C; Poduri A; Campbell AJ; Dimidschstein J; Møller RS; Lal D
    Epilepsia; 2020 Mar; 61(3):387-399. PubMed ID: 32090326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dominant SCN2A mutation with variable phenotype in two generations.
    Passi GR; Mohammad SS
    Brain Dev; 2021 Jan; 43(1):166-169. PubMed ID: 32893078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The phenotype and treatment of SCN2A-related developmental and epileptic encephalopathy.
    Kim HJ; Yang D; Kim SH; Kim B; Kim HD; Lee JS; Choi JR; Lee ST; Kang HC
    Epileptic Disord; 2020 Oct; 22(5):563-570. PubMed ID: 33000761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperexcitability and Pharmacological Responsiveness of Cortical Neurons Derived from Human iPSCs Carrying Epilepsy-Associated Sodium Channel Nav1.2-L1342P Genetic Variant.
    Que Z; Olivero-Acosta MI; Zhang J; Eaton M; Tukker AM; Chen X; Wu J; Xie J; Xiao T; Wettschurack K; Yunis L; Shafer JM; Schaber JA; Rochet JC; Bowman AB; Yuan C; Huang Z; Hu CD; Trader DJ; Skarnes WC; Yang Y
    J Neurosci; 2021 Dec; 41(49):10194-10208. PubMed ID: 34716231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infantile Epileptic Encephalopathy Associated With SCN2A Mutation Responsive to Oral Mexiletine.
    Foster LA; Johnson MR; MacDonald JT; Karachunski PI; Henry TR; Nascene DR; Moran BP; Raymond GV
    Pediatr Neurol; 2017 Jan; 66():108-111. PubMed ID: 27867041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.